Overview

Definition:
-Colonic stent placement is an endoscopic or radiologic procedure involving the insertion of a self-expanding metallic stent into a narrowed segment of the colon, typically caused by malignant strictures, to re-establish luminal patency
-This palliation aims to relieve symptoms of bowel obstruction and improve quality of life.
Epidemiology:
-Malignant colonic obstruction occurs in approximately 15-30% of patients with colorectal cancer, with a higher incidence in elderly patients or those with unresectable disease
-Colorectal cancer is the third most common cancer globally, contributing significantly to obstruction rates.
Clinical Significance:
-Colonic stenting offers a less invasive alternative to emergency surgery for malignant colonic obstruction, reducing morbidity and mortality associated with emergency laparotomy and ostomy creation
-It provides rapid symptom relief and allows for elective definitive treatment
-This procedure is crucial for surgical residents to understand in managing a common and complex oncological emergency.

Indications

Absolute Indications:
-Malignant colonic obstruction causing significant symptoms (pain, vomiting, distension) in patients unfit for immediate surgery
-Palliation of symptoms in unresectable or metastatic colorectal cancer
-Bridge to elective surgery in select patients.
Relative Indications:
-Benign strictures causing obstruction (e.g., post-radiation, inflammatory bowel disease) where surgery is high-risk
-Diversionary stoma reversal facilitation
-Intestinal decompression pre-operatively in high-risk patients.
Contraindications:
-Perforation
-Complete bowel obstruction with extensive necrosis
-Active peritonitis
-Uncontrollable coagulopathy
-Patients with very short life expectancy where the risks outweigh benefits.

Preoperative Preparation

Patient Assessment:
-Thorough history and physical examination focusing on symptoms of obstruction, comorbidities, performance status (ECOG/Karnofsky), and fluid/electrolyte balance
-Review of prior imaging and investigations.
Imaging:
-CT scan of the abdomen and pelvis with oral and IV contrast is essential to confirm the diagnosis, assess the level and extent of obstruction, identify the primary malignancy, and detect complications like perforation or distant metastases
-Colonoscopy may be performed to visualize the lesion and obtain biopsies.
Laboratory Tests:
-Complete blood count (CBC) for anemia and infection markers
-Liver function tests (LFTs) and renal function tests (RFTs) to assess organ function
-Coagulation profile to assess bleeding risk
-Electrolytes and serum albumin for nutritional status and fluid balance.
Bowel Preparation:
-Clear liquid diet for 24-48 hours pre-procedure
-In some cases, oral laxatives or polyethylene glycol solutions may be administered under medical supervision, though aggressive bowel preparation is often avoided in acute obstruction to prevent exacerbation of symptoms or perforation.

Procedure Steps

Endoscopic Approach:
-Under sedation or general anesthesia, a colonoscope is advanced to the stricture
-Guidewire insertion across the narrowed segment is crucial
-Balloon dilation may be performed prior to stent deployment
-The stent is then deployed under direct endoscopic visualization and fluoroscopic guidance
-Post-deployment imaging confirms stent position.
Radiologic Approach:
-Under local anesthesia and fluoroscopic guidance, a percutaneous tract is established across the stricture
-A guidewire is advanced through the obstruction
-Balloon angioplasty may be performed
-The stent is then deployed over the guidewire
-Access is typically obtained via a transperitoneal or transcolonic route.
Stent Types:
-Self-expanding metallic stents (SEMS) are commonly used
-Options include uncovered, partially covered, and fully covered stents
-Choice depends on the tumor location, risk of migration, and need for future resection.

Postoperative Care

Immediate Monitoring:
-Close monitoring for signs of bleeding, perforation, or stent migration
-Vital signs, abdominal examination, and pain assessment are critical
-Adequate intravenous fluid resuscitation and pain management are provided.
Pain Management:
-Opioid analgesics are typically required for immediate post-procedure pain
-Transition to oral analgesics as tolerated
-Patient-controlled analgesia (PCA) may be used.
Nutritional Support:
-Initiation of clear liquids followed by a low-residue diet as tolerated
-Parenteral or enteral nutrition may be required in cases of persistent ileus or significant malabsorption
-Education on dietary modifications to prevent further obstruction.
Ambulation And Discharge:
-Early ambulation is encouraged
-Discharge typically occurs within 24-72 hours if no complications arise
-Follow-up colonoscopy or imaging is scheduled as per institutional protocol, usually within 4-6 weeks, to assess stent patency and evaluate the tumor.

Complications

Early Complications:
-Perforation (0.5-5%)
-Bleeding (1-3%)
-Stent migration or displacement (2-7%)
-Abdominal pain
-Nausea and vomiting
-Peritonitis
-Sepsis.
Late Complications:
-Stent restenosis due to tumor ingrowth or overgrowth (5-15%)
-Stent fracture
-Impaction of stool
-Fistula formation
-Malignant recurrence.
Prevention Strategies:
-Meticulous technique during stent deployment
-Use of appropriate stent length and diameter
-Careful patient selection
-Aggressive pain and nausea management
-Post-procedure surveillance to detect early signs of complications
-Consideration of covered stents for specific indications.

Prognosis

Factors Affecting Prognosis:
-Stage of the underlying malignancy
-Patient's performance status and comorbidities
-Presence of distant metastases
-Success of stent placement in relieving obstruction
-Occurrence of complications.
Outcomes:
-Successful stent placement offers good palliation for symptoms of obstruction in up to 80-90% of patients, improving quality of life and enabling elective surgery in suitable candidates
-Median survival varies widely based on cancer stage and treatment, typically ranging from months to over a year.
Follow Up:
-Regular follow-up is essential, including clinical assessment, tumor marker monitoring (CEA), and imaging
-For palliation, follow-up focuses on symptom control and quality of life
-For patients undergoing bridge-to-surgery, follow-up is directed towards definitive cancer treatment and long-term oncological surveillance.

Key Points

Exam Focus:
-Indications for palliative stenting in malignant colonic obstruction
-Contraindications to stenting
-Complications of colonic stent placement
-Role of SEMS in managing acute colonic obstruction
-Differentiating SEMS from surgical options.
Clinical Pearls:
-Always ensure adequate guidewire passage across the stricture before stent deployment
-Fluoroscopy is vital for accurate stent positioning
-Close post-procedure monitoring for early detection of perforation is paramount
-Consider stent type based on tumor characteristics and risk of migration.
Common Mistakes:
-Inadequate pre-procedure assessment leading to inappropriate patient selection
-Failure to ensure adequate guidewire passage
-Misjudging the length of the stricture for stent selection
-Delaying management of complications
-Over-reliance on stenting in patients with very short life expectancy or active peritonitis.